Ali Erginay · enciclopedia

Publicaciones › Edema macular diabético y sus tratamientos

Symmetry in early response to intravitreal ranibizumab in bilateral diabetic macular oedema

Simetría en la respuesta temprana al ranibizumab intravítreo en edema macular diabético bilateral

Año2015
FuenteActa ophthalmologica
Tipoarticle · Journal Article
Autores (6)Margaux Guillard, Bénédicte Dupas, Mohamed El Sanharawi, Ali Erginay, Ramin Tadayoni, Pascale Massin
Posición de Erginay4 de 6
Citas4 (OpenAlex)
EnlacesDOI 10.1111/aos.12905 · PubMed 26564668 · OpenAlex · Texto completo en acceso abierto
LíneasEdema macular diabético y sus tratamientos Enfermedades vasculares, genéticas e inflamatorias de la retina Retinopatía diabética: clínica, función y progresión Imagen retiniana: OCT, OCT-angiografía y ultra-gran campo

En pocas palabras

Se estudió la respuesta al tratamiento con ranibizumab en pacientes con edema macular diabético en ambos ojos. Los resultados mostraron una respuesta simétrica en la mayoría de los pacientes, con mejoría en la agudeza visual y reducción del grosor macular. Esto sugiere que el tratamiento puede ser efectivo en ambos ojos de manera similar.

Resumen divulgativo generado automáticamente a partir del resumen original; puede contener imprecisiones.

Resumen original

PURPOSE: To study the symmetry in response to bilateral diabetic macular oedema (DME) treated with bilateral intravitreal injections of ranibizumab (IVR). METHODS: The charts of 36 eyes of 18 patients treated with a loading dose of three monthly IVR in both eyes were retrospectively reviewed. Favourable anatomical response was defined as a decrease by more than 10% in baseline central macular thickness (CMT), and favourable functional response was defined as an increase in visual acuity (VA) ≥5 letters. A symmetric response was defined as a similar anatomical and/or functional response in the first (FE) and second (SE) treated eyes. RESULTS: The VA improved significantly after ranibizumab treatment in both eyes (p < 0.01). A statistically significant positive correlation was found for the functional response to ranibizumab between the FE and the SE (R(2) = 0.26, p = 0.03). The mean CMT decreased significantly in both eyes (p < 0.01). A strong positive correlation was observed between the anatomical response to ranibizumab in the FE and the SE (R(2) = 0.37, p = 0.01). Symmetric favourable anatomical and functional responses were observed in 13 patients (72%). In two additional patients, an asymmetric functional response was observed despite a decrease in retinal thickness in both eyes. CONCLUSION: Symmetric anatomical and functional responses were observed in 72% of patients with DME after three initial IVR in each eye. This finding could be of clinical interest in the decision to treat the fellow eye, in a disease where a bilateral involvement is frequent.

Términos MeSH

Aged Angiogenesis Inhibitors Diabetic Retinopathy Female Humans Intravitreal Injections Macular Edema Male Middle Aged Ranibizumab Retrospective Studies Vascular Endothelial Growth Factor A Visual Acuity